Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria

Fertility and Sterility

Volumn 101, Issue 4, 2014, Pages

  Salameh, Wael A ^a   Redor Goldman, Mildred M ^a   Clarke, Nigel J ^a   Mathur, Ruchi ^b   Azziz, Ricardo ^b   Reitz, Richard E ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

androgens; mass spectrometry; Polycystic ovary syndrome; radioimmunoassays; testosterone

Indexed keywords

TESTOSTERONE;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; EQUILIBRIUM DIALYSIS; EXTRACTION CHROMATOGRAPHY RADIOIMMUNOASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MIDDLE AGED; NATIONAL HEALTH ORGANIZATION; OVARY POLYCYSTIC DISEASE; POPULATION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; TANDEM MASS SPECTROMETRY; TERTIARY CARE CENTER; YOUNG ADULT;

ANDROGENS; MASS SPECTROMETRY; POLYCYSTIC OVARY SYNDROME; RADIOIMMUNOASSAYS; TESTOSTERONE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; PRACTICE GUIDELINES AS TOPIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TESTOSTERONE; YOUNG ADULT;

EID: 84897144229     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.12.056     Document Type: Article

References (25)

1. R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, and W. Futterweit et al. Task Force on the Phenotype of the Polycystic Ovary Syndrome of the Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Fertil Steril 91 2009 456 488
2. M.L. Cawood, H.P. Field, C.G. Ford, S. Gillingwater, A. Kicman, and D. Cowan et al. Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practice Clin Chem 51 2005 1472 1479
3. Y.C. Chang, C.M. Li, L.A. Li, S.B. Jong, P.C. Liao, and L.W. Chang Quantitative measurement of male steroid hormones using automated on-line solid phase extraction-liquid chromatography-tandem mass spectrometry and comparison with radioimmunoassay Analyst 128 2003 363 368
4. D.A. Herold, and R.L. Fitzgerald Immunoassays for testosterone in women: better than a guess? Clin Chem 49 2003 1250 1251
5. A.M. Matsumoto, and W.J. Bremner Serum testosterone assays - accuracy matters J Clin Endocrinol Metab 89 2004 520 524
6. W. Rosner, R.J. Auchus, R. Azziz, P.M. Sluss, and H. Raff Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement J Clin Endocrinol Metab 92 2007 405 413
7. F.Z. Stanczyk Measurement of androgens in women Semin Reprod Med 24 2006 78 85
8. J. Taieb, B. Mathian, F. Millot, M.C. Patricot, E. Mathieu, and N. Queyrel et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children Clin Chem 49 2003 1381 1395
9. C. Wang, D.H. Catlin, L.M. Demers, B. Starcevic, and R.S. Swerdloff Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry J Clin Endocrinol Metab 89 2004 534 543
10. M.J. Wheeler Measurement of androgens Methods Mol Biol 324 2006 197 211
11. L.R. Boots, S. Potter, H.D. Potter, and R. Azziz Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability Fertil Steril 69 1998 286 292
12. D.J. Handelsman, and L. Wartofsky Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism J Clin Endocrinol Metab 98 2013 3971 3973
13. R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, and B.O. Yildiz The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2004 2745 2749
14. M. Asuncion, R.M. Calvo, J.L. San Millan, J. Sancho, S. Avila, and H.F. Escobar-Morreale A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain J Clin Endocrinol Metab 85 2000 2434 2438
15. E. Diamanti-Kandarakis, C.R. Kouli, A.T. Bergiele, F.A. Filandra, T.C. Tsianateli, and G.G. Spina et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile J Clin Endocrinol Metab 84 1999 4006 4011
16. B.O. Yildiz, and R. Azziz The adrenal and polycystic ovary syndrome Rev Endocr Metab Disord 8 2007 331 342
17. W.A. March, V.M. Moore, K.J. Willson, D.I. Phillips, R.J. Norman, and M.J. Davies The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria Hum Reprod 25 2010 544 551
18. R. Azziz, L.A. Sanchez, E.S. Knochenhauer, C. Moran, J. Lazenby, and K.C. Stephens et al. Androgen excess in women: experience with over 1000 consecutive patients J Clin Endocrinol Metab 89 2004 453 462
19. E. Carmina, F. Rosato, A. Jannì, M. Rizzo, and R.A. Longo Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism J Clin Endocrinol Metab 91 2006 2 6
20. J.K. Zawadzki, and A. Dunaif Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach A. Dunaif, J.R. Givens, F.P. Haseltine, G.E. Merriam, Polycystic ovary syndrome 1992 Blackwell Scientific Inc. Boston 377 384
21. E.S. Knochenhauer, T.J. Key, M. Kahsar-Miller, W. Waggoner, L.R. Boots, and R. Azziz Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study J Clin Endocrinol Metab 83 1998 3078 3082
22. W.A. Salameh, M.M. Redor-Goldman, N.J. Clarke, R.E. Reitz, and M.P. Caulfield Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges Steroids 75 2009 169 175
23. W.Y. Chang, E.S. Knochenhauer, A.A. Bartolucci, and R. Azziz Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups Fertil Steril 83 2005 1717 1723
24. A. Huang, K. Brennan, and R. Azziz Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria Fertil Steril 93 2010 1938 1941
25. U. Ezeh, B.O. Yildiz, and R. Azziz Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome J Clin Endocrinol Metab 98 2013 E1088 E1096